Business Description
Biora Therapeutics was a San Diego-based biotech company focused on creating medicines that patients could swallow rather than inject, targeting conditions like inflammatory bowel disease and other chronic illnesses. The company developed two delivery platforms designed to get treatments precisely where they needed to go inside the body, either within the digestive tract or into the broader bloodstream. Founded in 2010 and formerly known as Progenity Inc., the company filed for bankruptcy protection in late 2024, and those proceedings were converted to a liquidation process in May 2025.
